0
The QualityStocks Daily Friday, May 28th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(VTNR) $7.8100 +95.74%

MarketClub Analysis(LEDS) $13.8200 +44.86%

NetworkNewsWire(SGTM) $2.2000 +25.71%

The QualityStocks Daily Stock List

Aptorum Group Limited (NASDAQ: APM)

RedChip, QualityStocks, MarketClub Analysis, Red Chip, InvestorPlace, StreetInsider, StockMarketWatch and MarketBeat reported earlier on Aptorum Group Limited (APM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aptorum Group Limited (NASDAQ: APM) (FRA: A1V) is a pharmaceutical firm that is focused on discovering, developing and commercializing therapies for treating various ailments, with a focus on cancers and infectious ailments.

The firm has its headquarters in London, in the United Kingdom and was founded in 2010, on September 13th by Ian Huen. It serves clients across the globe and operates in the healthcare sector, under the biotech and pharma sub-industry.

The company operates through the non-therapeutics and therapeutics segment. The former segment (non-therapeutics) is made up of diagnostics projects which include the sale of natural supplements, AML clinic and a new molecular-based rapid pathogen detection and identification diagnostic tool. On the other hand, the latter segment (therapeutics) is involved in the development of drug molecules and particular technologies for diagnosing and treating human diseases.

The enterprise’s pipeline is made up of various products, among them Claves, Nativus, RPIDD, Acticule and Smart-Act series. It has a few products in preclinical development, including DOI NLS-2, CLS-1, ALS-3, ALS-2, ALS-1 and ALS-4. Additionally, it has developed a product indicated for the treatment of neuroblastoma dubbed SACT-1 for the treatment of neuroblastoma. The enterprise is also centered on pursuing diagnostic projects and therapies in women’s health, metabolic disorders, gastroenterology, neurology and other areas. Furthermore, it has projects that center on natural supplements for women undergoing menopause and those who experience related symptoms as well as in surgical robotics.

The company recently entered into an agreement with Exeltis for the development and commercialization of a preclinical candidate that targets women’s health and gynecological conditions, and in particular endometriosis, which affects about 10% of women within the reproductive age. This product may help address unmet needs, which will be beneficial to the patients in need as well as the firm’s stakeholders.

Aptorum Group Limited (APM), closed Friday’s trading session at $2.80, off by 1.7544%, on 214,277 volume. The average volume for the last 3 months is 881,067 and the stock's 52-week low/high is $0.564999997/$19.7999992.

Creative Realities Incorporated (NASDAQ: CREX)

MarketBeat, QualityStocks, MarketClub Analysis, StockMarketWatch and StreetInsider reported earlier on Creative Realities Incorporated (CREX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Creative Realities Incorporated (NASDAQ: CREX) (FRA: 4U7) is engaged in the provision of digital marketing technology solutions to enterprises, individual retail brands, retail firms and other bodies in Canada and the U.S.

The firm, which is a subsidiary of Slipstream Communications LLC, has its headquarters in Louisville, Kentucky. It was incorporated in 1997 and operates in the communications sector, under the media industry in the advertising and marketing sub-industry.

The enterprise’s solutions and technology include kiosks and advisors, interactive digital shopping assistants, omni-channel customer engagement systems and digital merchandising systems, among other interactive marketing technologies (including beaconing, point-of-sale transactions, social media, mobile and web-based media) which allow businesses to engage with customers.

The company also offers software licenses, field services, implementation, engineering, software development, content development and production, experience design and consulting, as well as support and maintenance services related to its managed systems, software and solutions. It sells its solutions to the pharmacy retail industry, mobile operators, mass merchants, luxury, gaming, financial services, quick service restaurants/food service, fitness, fashion, electronics, digital out-of-home, department stores, CPG, beauty, children/baby, baking, accessories and apparel and the automotive industries. The company’s customers include Travelocity, Nine West, Thomson Reuters, Sunglass Hut, KFC, Estee Lauder, Ford, Adidas, Carnival, Calvin Klein, Chrysler Canada, Rite Aid and Macy’s.

The firm recently announced its first quarter financial results, which highlight that it achieved breakeven operating results. It is currently working on strengthening its competitive position and market perception through new opportunities which are bound to boost growth as well as investments into the firm.

Creative Realities Incorporated (CREX), closed Friday’s trading session at $2.13, off by 4.9107%, on 765,706 volume. The average volume for the last 3 months is 979,898 and the stock's 52-week low/high is $0.86/$3.63.

Soligenix Inc. (NASDAQ: SNGX)

QualityStocks, Streetwise Reports, PCG Advisory, StockMarketWatch, MarketBeat, TradersPro, TraderPower, AllPennyStocks, FeedBlitz, SmallCapVoice, PennyStocks24, Stockgoodies, The Street, BUYINS.NET, Marketbeat.com, MarketClub Analysis, OTC Markets Group, Pennybuster, HotOTC, PennyStockDD, PennyTrader Publisher, alert, ProActive Capital, Zacks, Schaeffer's, Stock Beast, Stock Rich, StockEgg, StockOodles, UltimatePennyStock and Pick Alerts reported earlier on Soligenix Inc. (SNGX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Soligenix Inc. (NASDAQ: SNGX) (FRA: DOA3) is a late-stage biopharmaceutical firm that is engaged in the development and commercialization of products to treat rare ailments like gastrointestinal graft-versus-host disease in the U.S. It also develops vaccines for civilian and military applications.

The firm has its headquarters in Princeton, New Jersey and was founded in 1987. Prior to its name change in 2009, the firm was known as DOR BioPharma Inc. It operates as part of the healthcare sector, under the biotech and pharma sub-industry.

The company operates through the public health solutions and specialized biotherapeutics segments. The former segment is involved in developing a vaccine candidate indicated for coronavirus prevention dubbed CiVax; a technology designed for vaccine thermo-stabilization called ThermoVax; a drug formulation indicated for treating antibiotic-resistant and emerging infectious ailments like Ebola dubbed SGX943, which is in pre-clinical stage and a ricin toxin candidate dubbed RiVax, which recently concluded phase 1 clinical trials. On the other hand, the latter segment provides proprietary oral formulations which recently concluded phase 1 and 2 clinical trials evaluating their effectiveness in treating gastrointestinal disorders characterized by serious inflammation. These include candidates developed for the treatment of pediatric Crohn’s disease and acute radiation enteritis dubbed SGX203 and SGX201, respectively.

The enterprise was recently awarded a patent for its (SGX301) HyBryte formulation. This move not only expands, protects and strengthens its synthetic hypericin patent estate but also brings them closer to marketing approval and commercialization of their SGX301 candidate, which has been indicated for CTCL, a class of non-Hodgkin’s lymphoma.

Soligenix Inc. (SNGX), closed Friday’s trading session at $1.02, up 2%, on 291,419 volume. The average volume for the last 3 months is 1,574,467 and the stock's 52-week low/high is $0.125/$1.20000004.

Verastem Inc. (NASDAQ: VSTM)

MarketClub Analysis, MarketBeat, StockMarketWatch, StreetInsider, BUYINS.NET, InvestorPlace, QualityStocks, TraderPower, Marketbeat.com, Streetwise Reports, RedChip, TopStockAnalysts, Promotion Stock Secrets, The Street, Schaeffer's, TradersPro, Barchart, The Online Investor, TheStockAdvisors, Jason Bond, Tiny Gems, Investing Futures and Dividend Opportunities reported previously on Verastem Inc. (VSTM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Verastem Inc. (NASDAQ: VSTM) (FRA: 2VS) is a development-stage biopharmaceutical firm that is engaged in developing and commercializing therapies to improve the life of cancer patients.

The firm has its headquarters in Needham, Massachusetts and was founded in 2010, on August 4th by Christoph H. Westphal, Robert F. Weinberg, Eric S. Lander, Satish Jindal, Piyush Gupta, Michelle Dipp and Richard H. Aldrich. It serves healthcare professionals and patients in the U.S. and operates in the health care sector, under the biotech and pharma sub-industry.

The company is party to license agreements with Pfizer Inc. for researching, developing, manufacturing and commercializing products which contain Pfizer’s FAK inhibitors for prophylactic, diagnostic and therapeutic uses in people; and Chugai Pharmaceutical Co. Ltd for developing, commercializing and manufacturing products which contain VS-6766.

Its products include a formulation which is in its phase 2 trial to evaluate the safety of defactinib in combination with VS-6766, called RAMP 2020. The formulation is used in patients with KRAS mutant non-small cell lung cancer. Defactinib is an oral small molecule inhibitor of FAK (focal adhesion kinase). In addition, the company is also develops RAMP 201 to evaluate the safety and effectiveness of VS-6766 in combination with an oral small molecule inhibitor. This is in addition to developing VS-6766, a dual RAF (rapidly accelerate fibrosarcoma) MEK (mitogen-activated protein kinase) inhibitor, which blocks RAF’s ability to phosphorylate MEK as well as blocking MEK kinase activity.

The company recently received Breakthrough Therapy designation for its VS0-6766 candidate from the FDA. This will allow them to possibly bring a new therapy to the market, which will not only benefit the patients with low-grade serous ovarian cancer but also encourage more investments into the firm.

Verastem Inc. (VSTM), closed Friday’s trading session at $3.87, off by 3.25%, on 4,194,667 volume. The average volume for the last 3 months is 2,642,759 and the stock's 52-week low/high is $0.493800014/$2.23499989.

Strongbridge Biopharma PLC (NASDAQ: SBBP)

StockMarketWatch, TraderPower, MarketBeat, StreetInsider, QualityStocks, BUYINS.NET, TradersPro, StockRockandRoll, PennyStockLocks, Penny Stock 101 and Daily Market Beat reported beforehand on Strongbridge Biopharma PLC (SBBP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Strongbridge Biopharma PLC (NASDAQ: SBBP) (FRA: 69BN) is a commercial-stage biopharmaceutical firm that is engaged in acquiring, developing, licensing and commercializing therapeutics for the treatment of rare ailments with unmet needs in the U.S.

The firm has its headquarters in Trevose, Pennsylvania and was incorporated in 1996. Prior to its name change in September 2015, the firm was known as Cortendo PLC. It operates as part of the healthcare sector, under the biotech and pharma sub-industry. The firm distributes their products across the globe.

The enterprise’s objective is to build its franchise around rare endocrine disorders with highly unmet needs for innovative treatment options. Its franchise-based model permits leveraging firm expertise in both the commercial and clinical development realms, to offer a range of therapeutically-aligned products.

The company’s product pipeline is made up of a somatostatin analog COR-005 which recently concluded phase 2 clinical trials evaluating its efficacy in treating acromegaly; a cortisol synthesis inhibitor currently in phase 3 clinical trials dubbed COR-003 (Recorlev) which has been developed to treat endogenous Cushing’s syndrome and an oral anhydrase inhibitor dubbed Keveyis (dichlorphenamide), which is indicated for the treatment of hypokalemic, hyperkalemic and associated variants of primary periodic paralysis.

The company’s Keveyis, COR-005 and COR-003 candidates have been granted orphan drug designations by the U.S. FDA, with the latter two also receiving the designation from the European Medicines Agency. In addition, it has entered into a definitive agreement with Xeris Pharmaceuticals Inc. for the acquisition of the firm’s contingent value rights and stock. This move will drive the company’s next phase of growth and allow them to gain additional financial resources and scale to better address the unmet needs of the consumers they serve, which will boost investments into the firm.

Strongbridge Biopharma PLC (SBBP), closed Friday’s trading session at $2.52, off by 4.1825%, on 1,018,200 volume. The average volume for the last 3 months is 1,308,195 and the stock's 52-week low/high is $1.87/$4.63.

Casa Minerals, Inc. (CASXF)

We reported earlier on Casa Minerals, Inc. (CASXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Casa Minerals, Inc. engages in the acquisition, exploration and development of mineral properties situated in Canada. It owns a 100 percent interest in the polymetallic Pitman and Keaper properties and has an option to acquire a 75 percent interest in the Arsenault VMS Property. The Company primarily explores for gold, copper, silver, as well as molybdenum. Casa Minerals has its head office in Vancouver, British Colombia. The Company lists on the OTC Markets.

The Pitman Property consists of seven contiguous mineral tenures encompassing 5,506 hectares. It is positioned 20 kilometers north of Terrace, British Columbia. The Pitman Property includes a number of historic prospects. These include the Pitman copper-molybdenum ± silver prospect, and the Gold Dome and Paddy Mac gold-base metal prospects.

The polymetallic Keaper Property is 20 kilometers northeast of Terrace, British Columbia. This Property consists of 3,790 hectares. It is undergoing exploration for copper, silver and gold. Planning and permitting for exploration of Casa Minerals’ properties is in progress.

The Company’s Arsenault VMS Property consists of three mineral tenures encompassing roughly 2,751 hectares positioned in the Atlin Mining Division, British Columbia. In recent years, Casa has conducted a number of exploration programs on the Arsenault Property. It has developed an attractive volcanogenic massive sulphide (VMS) exploration target. More work is planned with the goal of proceeding to a drilling program to test a number of areas identified by geological mapping, prospecting, and geophysical and geochemical surveys.

Recently, Casa Minerals announced the appointment of Mr. Jim (James) D. Clucas to its Board of Directors. Mr. Jim Clucas brings considerable experience and management skills gained from executive roles in senior and junior levels of mineral exploration, mining and development to Casa Minerals. Mr. Clucas is a Co-Founder of INV Metals presently trading on the TSX Venture Exchange. He was previously the Executive Chairman and President of Search Minerals, Inc., also a TSX Company.

Casa Minerals, Inc. (CASXF), closed Friday’s trading session at $0.2216, off by 9.6248%, on 19,191 volume. The average volume for the last 3 months is 1,844 and the stock's 52-week low/high is $0.109999999/$0.870000004.

Greene Concepts, Inc. (OTC: INKW)

QualityStocks, PennyTrader, Penny Picks, HotOTC, Damn Good Penny Picks, Wall Street Mover, PREPUMP STOCKS, Penny Stock Newsletter, MicroCapDaily and MegaPennyStocks reported previously on Greene Concepts, Inc. (INKW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Greene Concepts, Inc. (OTC: INKW) manages a beverage and bottling firm in Marion, North Carolina through Mammoth Ventures Inc., its wholly-owned subsidiary.

The company is based in Clovis, California and was founded in 1952, on August 18th by Leonard M. Greene. Its product line is made up of enhanced athletic drinks, beverage offerings, artesian and spring water as well as ketogenic and CBD-infused beverages. The company is focused on delivering water to its consumers directly.

Its Marion plant is a 60,000 ft2 bottling and beverage facility that is found within the Pisgah National Forest boundaries. The plant’s water source is a combination of 7 artesian and spring wells that are fed from a natural aquifer found in the Pisgah forest. Mammoth Ventures is also a 3rd party bottler and producer of ‘white label’ water and beverage products. These services are offered to clients that would like to market their own product formulations, labeling and brand name while outsourcing the bottling and production of their products to Mammoth. Through its Water Club Inc. subsidiary, the company is pursuing subscription-based delivery of scientifically formulated beverages and water directly to the consumer’s markets and homes.

The firm recently hired an auditing company to audit its financials, in preparation for an up list to the NASDAQ. This could not only lead to a change in its stock symbol but also attract more investors, which will boost both the firm’s share prices as well as its growth.

Greene Concepts, Inc. (INKW), closed Friday’s trading session at $0.0163, up 28.3465%, on 32,262,211 volume. The average volume for the last 3 months is 27,035,975 and the stock's 52-week low/high is $0.059999998/$3.65000009.

Triad Pro Innovators, Inc. (TPII)

QualityStocks, Small Cap Firm, Penny Picks, Damn Good Penny Picks, AwesomeStocks, StockRockandRoll, PennyStockLocks and Penny Stock 101 reported previously on Triad Pro Innovators, Inc. (TPII), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Triad Pro Innovators, Inc. operates as a renewable energy producer and storage provider. The Company owns and operates combined heat and power renewable energy facilities in California and the Western U.S. It previously went by the name Shing-Mei International, Inc. It changed its name to Triad Pro Innovators, Inc. in January of 2012. Established in 1994, Triad Pro Innovators has its corporate headquarters in La Quinta, California.

The Company’s focus is revolutionizing worldwide transportation and energy storage. It also engages in the purchase and sale of power generation equipment, and in the operation, repair, and maintenance of power generation equipment for other energy facility owners. Furthermore, Triad Pro Innovators provides energy storage solutions for residential, small business, industrial, as well as utility applications.

Triad Pro Innovators has its TriadPro eCell. This pioneering storage system replaces toxic batteries and is eco-friendly. TriadPro eCell stores electricity rapidly and charges in minutes. In addition, it requires no maintenance or routine replacement and includes a 10 year warranty.

The Company also has its SPREE (Solar Powered Renewable Electric Energy) golf carts. SPREE is the world’s first, completely solar-powered golf cart. SPREE golf carts will provide considerable reductions in energy costs for golf courses and individual golfers. The SPREE continuously tops off its maintenance-free eCell energy storage device utilizing its roof-mounted solar panel. The SPREE delivers automotive style performance with a quiet, smooth range of power. It has spacious seating, a taller roof design, and a powerful and comfortable ride.

The anticipation is that worldwide consumption of golf carts will surpass 225,000 units in 2023, in a multi-billion dollar industry, valued at U.S. $2.3 Billion of which 41 percent is projected to be the North American market. Triad Pro Innovators projects achieving roughly $70,000,000 global sales of traditional golf and people mover vehicles by the end of its third production year. The Company’s entrance and growth in this market is because of the utilization of its proprietary eCell, which will accept electrical energy using solar power or electricity.

Triad Pro Innovators, Inc. (TPII), closed Friday’s trading session at $0.064, up 36.4024%, on 712,915 volume. The average volume for the last 3 months is 977,362 and the stock's 52-week low/high is $0.0061/$0.195.

Bespoke Extracts, Inc. (BSPK)

We reported previously on Bespoke Extracts, Inc. (BSPK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. Bespoke Extracts is headquartered in Sunny Isles Beach, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s products are marketed as dietary supplements and distributed through the Company’s direct-to-consumers e-commerce store. Bespoke’s products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. CBD (cannabidiol) is one of over 85 cannabinoids found in cannabis. CBD is present in more significant quantities in hemp than it is marijuana.

Bespoke Extracts’ mission is to become one of the world’s most trusted sources for premium quality, all-natural, USA-grown, hemp-derived cannabidiol (CBD) products for the nutraceutical and veterinary markets. The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke’s farmers have been innovators in hemp agriculture, farming practices, agrotech, as well as production for generations. Bespoke’s hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.

The Company’s products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. Moreover, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.

Bespoke Extracts announced this past November that its Board of Directors appointed Niquana (Nikki) Noel as President and Chief Executive Officer (CEO), effective immediately. Serving Bespoke as its Operations Manager, Noel assumed day-to-day leadership of the Company and joined its Board of Directors. Noel has spent close to two decades working with privately-held and publicly-traded micro and small cap companies.

Bespoke Extracts, Inc. (BSPK), closed Friday’s trading session at $0.028, up 21.7391%, on 329,900 volume. The average volume for the last 3 months is 669,348 and the stock's 52-week low/high is $0.01/$0.1.

Kalytera Therapeutics, Inc. (KALTF)

We reported previously on Kalytera Therapeutics, Inc. (KALTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Kalytera Therapeutics, Inc. is pioneering the development of a next generation of cannabinoid therapeutics. The Company is working to establish a leading position in the development of novel cannabinoid medicines for an array of important unmet medical needs, with an initial focus on Graft versus Host Disease (GvHD). Kalytera Therapeutics has its U.S. headquarters in Novato, California. A clinical-stage pharmaceutical company, its research facility is in Israel.

Kalytera Therapeutics is also developing a new class of proprietary cannabidiol (CBD) therapeutics. Its intention is to explore the use of CBD, a non-psychoactive cannabis constituent. The Company is working to advance a portfolio of synthetic, non-psychoactive cannabis-like molecules. Additionally, Kalytera will center on orphan conditions, with the aim of generating data in humans that may support follow-on studies in major conditions.

Kalytera received approval from the Institutional Review Board (IRB) at one of two clinical sites in Israel. This is to begin a Phase 2 study to evaluate cannabidiol (CBD) for the prevention of GvHD. The proposed study is a Phase 2, open label, multicenter trial. The trial is to evaluate the pharmacokinetic profile, safety, and efficacy of numerous doses of CBD for the prevention of GvHD following allogeneic hematopoietic cell transplantation (HCT). The proposed study will take place at the Rabin Medical Center, Beilinson, and the Rambam Health Care Campus, Haifa, in Israel.

The expectation is that Kalytera’s continuing Phase 2b clinical study evaluating the use of CBD in the prevention of GVHD will be completed early this year. Upon completion of the Phase 2b clinical study, Kalytera will begin preparations for the pivotal Phase 3 clinical study that will be required for Food and Drug Administration (FDA) approval.

The work that Kalytera Therapeutics is doing in GVHD consists of two separate product development programs. One is a program evaluating CBD for the prevention of acute GVHD. A separate program is evaluating CBD for the treatment of acute GVHD. The Company’s program in prevention of acute GVHD is more advanced than is the program in treatment of acute GVHD.

Kalytera Therapeutics is the exclusive licensee of two issued U.S. patents covering the use of CBD in the prevention and treatment of GVHD. It is also the exclusive licensee of pending patent applications in other jurisdictions for the use of CBD in the prevention and treatment of GVHD.

Recently, Kalytera Therapeutics announced positive interim data from its continuing Phase 2 clinical study evaluating cannabidiol (CBD) for the prevention of acute graft versus host disease (GVHD) following bone marrow transplant. Interim data from the initial 12-patient cohort support the following key findings to date.

No patients receiving oral CBD at the lowest study dose of 75 mg twice daily (BID) have developed grades 3 or 4 acute GVHD. One patient developed grade 2 acute GVHD, the least serious form of the disease. CBD has demonstrated a good safety and tolerability profile, with no significant adverse events relating to its use.

Kalytera Therapeutics, Inc. (KALTF), closed Friday’s trading session at $0.037, up 23.3333%, on 83,138 volume. The average volume for the last 3 months is 626,936 and the stock's 52-week low/high is $0.324999988/$1.14999997.

US Nuclear Corp. (UCLE)

QualityStocks, Innovative Marketing, Stock News Now, PoliticsAndMyPortfolio, Wall Street Mover, TopPennyStockMovers and MarketBeat reported previously on US Nuclear Corp. (UCLE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

US Nuclear Corp. is a leader in radiation detection. It develops, manufactures, and also sells radiation detection and measuring equipment internationally. The Company has 100 plus years of experience providing quality Chemical Radiation Detection and Monitoring Instrumentation. US Nuclear is headquartered in Canoga Park, California. The Company lists on the OTC Markets Group’s OTCQB.

US Nuclear has three operating divisions: (Technical Associates (TA)), Overhoff Technology (OTC), and Electronic Control Concepts (ECC). Through these divisions, the Company supplies first-class instrumentation to any industry utilizing radionuclides. These industries include nuclear power plants, national laboratories, government agencies, homeland security, military, and universities and schools. Additionally, industries include research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants.

US Nuclear provides measurement instrumentation for the nuclear energy industry and for developing technological processes including Fusion, Thorium and Molten Salt (MSR) reactor technologies domestically and worldwide. American and International customers include United States Government Agencies, the U.S. Military, Homeland Security, National Laboratories, Universities, Hospitals, nuclear reactor facilities in the USA, China, Canada, South Korea, Argentina, Russia, and others.

US Nuclear also engages in Product Development. Its newest product development is the incorporation of radiation and chemical sensors with drone mounted platforms. Its strategic partnership with FlyCFam UAV provides a complete package to a customer that flies in all-weather, heavy winds, and with a heavy payload. This provides the opportunity to fly many sensors at one time with real-time wireless download.

US Nuclear has a strategic alliance agreement with QYSEA Technology. This agreement is to market, build, sell, as well as service Industrial Underwater Robot Sensor Systems in the United States and globally.

US Nuclear and Grapheton’s implantable bioelectronic sensors can be used to help treat millions of people around the world suffering from mobility problems. Neuroscientists stress there is a large unmet demand to develop implantable sensors and the Artificial Intelligence (AI) required to translate the brain signals into specific commands or actions. US Nuclear has a 40 percent stake in Grapheton.

Grapheton’s innovative, patented bioelectronic implants lead the world in bio-compatibility and longevity. Grapheton has developed various kinds of implantable brain sensors, including ECoG (electrocorticography- monitoring the electrical activity of the brain), spinal stimulation probes, and brain chemical sensors, all of which are already in use at different research centers. Grapheton’s probes are biocompatible, therefore avoiding inflammation. US Nuclear said that it and Grapheton’s brain-machine interface technology has great potential for helping immobilized patients gain mobility once again and perform actions that would have never been possible without this pioneering product.

US Nuclear Corp. (UCLE), closed Friday’s trading session at $0.79, up 27.4194%, on 254,143 volume. The average volume for the last 3 months is 51,821 and the stock's 52-week low/high is $0.629999995/$2.29999995.

Bimini Capital Management, Inc. (BMNM)

QualityStocks, Wall Street Resources, StockOodles, MarketBeat and The Street reported previously on Bimini Capital Management, Inc. (BMNM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bimini Capital Management, Inc., through its subsidiaries, engages in the asset management business in the U.S. It operates via two segments, Asset Management and Investment Portfolio. The Company invests in, but is not limited to investing in, residential mortgage-related securities issued by the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac) and the Government National Mortgage Association (Ginnie Mae). OTCQB-listed, Bimini Capital Management is based in Vero Beach, Florida.

By way of its wholly-owned subsidiary, Bimini Advisors Holdings, LLC, Bimini Capital Management serves as the external manager of Orchid Island Capital, Inc. Orchid Island Capital is a publicly-traded Real Estate Investment Trust – REIT, (NYSE: ORC). Orchid is managed to earn returns on the spread between the yield on its assets and its costs. This includes the interest expense on the funds it borrows.

As Orchid’s external manager, Bimini Advisors Holdings receives management fees and expense reimbursements for managing Orchid's investment portfolio and daily operations. Bimini Advisors provides Orchid with its management team, including its officers, along with appropriate support personnel.

Bimini Capital Management also manages the portfolio of its wholly-owned subsidiary, Royal Palm Capital, LLC. Royal Palm is managed with an investment strategy alike to that of Orchid Island Capital.

Concerning Capital Allocation and Return on Invested Capital, Bimini Capital Management allocates capital between two MBS sub-portfolios, the pass-through MBS portfolio (PT MBS) and the structured MBS portfolio, comprising interest only (IO) and inverse interest-only (IIO) securities.

Bimini Capital Management, Inc. (BMNM), closed Friday’s trading session at $1.65, up 20.438%, on 28,213 volume. The average volume for the last 3 months is 4,228 and the stock's 52-week low/high is $0.100000001/$4.73999977.

/div>

Featured Whitepapers

A Case for Small & Micro-Cap Investing

Avenel Financial Group’s (AFG) financial research analysts and interns researched the top performing Microcap investors, studied their investments, and analyzed quantitative and qualitative metrics along with the historical performance of this asset class.

Read More...

Featured Whitepaper

XPEL Case Study

Did You Miss Your Opportunity on This 100-Bagger?

As a continuation of our study of Super Compounders we will evaluate one of the more prominent 100-Baggers of the past decade. XPEL technologies is a company that has rose to dominate the niche space of protective films for car paint and has rapidly grown through intelligent capital allocation and acquisitions. Paul Andreola of Smallcap Discoveries first brought this to MicroCapClub in 2013. Attached is an in-depth analysis of its meteoric rise, which we hope will help you to spot the next 100-Bagger.

Read More...

Featured Whitepaper

Quality Shareholders

Lawrence A. Cunningham discussed the makeup of the modern shareholder group in his recent book “Quality Shareholders.” In this paper we briefly discuss the primary takeaways and applications of the concepts in this book and the advantages inherent in the active cultivation of a quality, engaged shareholder cohort. The insights in Cunningham’s book are impactful and may illuminate new strategies for evaluating a firms management.

Managers get the shareholders they deserve.” – Lawrence Cunningham

Read More...

 

The QualityStocks Company Corner

AmpliTech Group Inc. (NASDAQ: AMPG)

The QualityStocks Daily Newsletter would like to spotlight AmpliTech Group Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW).

AmpliTech Group (NASDAQ: AMPG) recently announced it had been selected by a major Fortune 200 defense contractor to provide its ultra-low noise amplifiers. The selection, founder and CEO Fawad Maqbool says, was because of the company’s emphasis on leading-edge performance in amplifiers, as well as its ability to deliver the highest quality. “Given the rigors of launching and the requirement to maintain the highest performance in a space orbit for many years, AmpliTech builds these parts using specially developed techniques and procedures that it has continually perfected,” reads a recent article. “The company focuses on being a reliable supplier of high-quality amplifiers for use in situations where the best performance is needed.” To view the full article, visit https://ibn.fm/cy3jq

AmpliTech Group Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) designs, develops and manufactures custom radio frequency (RF) components for the commercial, SATCOM, space and military markets. In addition to developing new products for the 5G/6G wireless ecosystem and infrastructure, the company has placed focus on the development of leading-edge solutions in quantum computing in support of U.S. efforts to reach the coveted position of quantum supremacy. The company maintains a commitment to R&D that allows it to remain at the forefront of emerging technologies. AmpliTech aims to use its advanced techniques and IP to provide tomorrow’s technology today, improving everyone’s quality of life.

AmpliTech was founded by Fawad Maqbool in 2002 to fill the need for affordable, high-quality, customized and state-of-the-art amplifiers and components. Headquartered in Bohemia, New York, the company currently has distributors and representatives available worldwide.

Product Portfolio

AmpliTech’s mission is to develop quality, state-of-the-art microwave amplifiers by leveraging its experience, proven technical expertise and superior design heritage. The company’s products cover a frequency range from 50 kHz to 44 GHz, with plans to eventually offer designs up to 100 GHz. Its current catalog includes:

Amplifiers

Passive Components

All the company’s products come with a satisfaction guarantee, as the company is fully committed to providing only high-quality products free from manufacturing and material defects and guaranteed to perform according to applicable specifications.

Consulting Services

Leveraging more than 100 years of combined experience in microwave systems and component design ranging from active components to passive devices, AmpliTech also provides valuable consulting services and technical assistance to its customers.

With capabilities ranging from initial design to final manufacturing and delivery, the company’s team also offers project management services and advice on both technical aspects and how to handle business issues such as resource allocation, customer contact, budget restraints, time limits and more.

Other key benefits of AmpliTech consulting services that can give its customers a definitive edge include:

  • Timely technical assistance
  • Little or no learning curve
  • Less long-term costs associated with full-time employees with benefits and salaries
  • Availability when necessary
  • Customer support with schedules, project management and on the job training
  • Access to technology
  • Partnering for manufacturing and/or complete turn-key product solution
  • Personal guidance from concept to development
  • Custom designs for each application

Market Outlook

The global microwave devices market was valued at $7.44 billion in 2019 and is expected to grow at a CAGR of 3.23% and reach $9 billion by 2025 (https://nnw.fm/zqMEk). Governmental expenditures in the defense and space communications sectors are expected to expand the opportunities for growth within the industry.

AmpliTech continues to follow its strategy of identifying key elements in today’s technological revolution. It is leveraging its technical expertise and experience to align product portfolios and IP with innovation (https://nnw.fm/rVzxX). The company has plans to be a catalyst in the enhancement, development and distribution of breakthroughs in the following sizeable markets:

  • High Speed Terrestrial and Satellite Terminals (SATCOM, “Internet in the Sky”)
  • 5G/Wi-Fi6E and 6G wireless infrastructure (Cellular Base Stations, Small Cells, Private Wi-Fi Networks)
  • IoT (Internet of Things)
  • Cloud Farms, Big Data and MEC architecture
  • Quantum Supercomputers/Quantum Research
  • Deep Space Astronomy
  • Autonomous Self-Driving Vehicles
  • Telemedicine, AR/VR (Augmented and Virtual Reality)
  • Drones, UAVs (Unmanned Aerial Vehicles)
  • Cyber-security
  • Military/Defense ECM/EW

Management Team

Fawad Maqbool is the Founder, President, CEO and CTO of AmpliTech Group Inc. He has been in the microwave industry for over 30 years. Mr. Maqbool spent 14 years developing state-of-the-art amplifiers and components for MITEQ Inc., a leading microwave and communications equipment supplier. He founded AmpliComm in 2000, which was subsequently acquired by Aeroflex Inc. Mr. Maqbool has management and design experience, which has led to the development of microwave technology on a commercial and military level. He holds a B.S.E.E in Microwave Engineering and a B.S.E.E in Bio-Medical Engineering from CUNY and an M.S.E.E from the Polytechnic University of New York.

Louisa Sanfratello is the company’s CFO. She is a Certified Public Accountant (CPA) and has worked in various industries since 1998. During this time, she held roles as an accountant for charities and schools, consisting of the preparation of official financial documents and day-to-day financial management requirements. Ms. Sanfratello began her professional career in 1987 at Holtz, Rubinstein & Co., a public accounting firm. She gathered two years of experience there before gaining her CPA and taking on more challenging roles.

Brandon Worster is the company’s Director of Engineering. He joined AmpliTech at the end of 2019, bringing over 14 years of design and management experience. His specialty is Low Noise and Medium Power Amplifiers, but Mr. Worster also has vast experience with various systems, including RF/Microwave devices and systems. He holds a master’s degree in electrical engineering and is an adjunct professor at Farmingdale University in New York.

John P. Pastore is AmpliTech’s Director of Sales. He has worked in the microwave industry for more than 35 years, including time with some of the industry’s leading names. Mr. Pastore is a hands-on professional who has experience that spans over 20 years with progressive roles that blend technical, manufacturing, customer service and management expertise. He is an extremely valuable asset to the company as it moves forward due to his business savvy approach and deep industry knowledge. He has a B.S. in Business Management.

M. Syed handles Technical Sales and is the company’s Director of IT. He is an electrical engineer with more than 10 years of business experience. Since 2011, he has led Technical Sales for AmpliTech, and he recently became the President and CEO of his own company while also serving as Chief Technical Sales consultant for numerous other companies and groups in New York City. Mr. Syed has been in the IT industry for 25 years. He is a Computer Engineer by trade and a Certified Netware Engineer and Microsoft Certified Systems Engineer.

AmpliTech Group Inc. (AMPG), closed Friday’s trading session at $4.54, up 4.1284%, on 135,362 volume. The average volume for the last 3 months is 867,976 and the stock's 52-week low/high is $3.55/$19.80.

Recent News

BAND Royalty

The QualityStocks Daily Newsletter would like to spotlight BAND Royalty.

BAND Royalty announces the availability of a syndicated broadcast titled, “NFTs Flipping the Script, Bringing Value Back to Music Artists.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast. To view the full editorial, please visit: https://nnw.fm/dvON4. NFTs, one-of-a-kind assets stored and verified on immutable blockchain technology exploded on the scene in 2021, headlined by Christie’s auctioning a collection of Beeple’s digital artwork for $69.3 million in March. During the first quarter of 2021, NFT sales exceeded $2 billion, up more than 20-fold from $93 million in Q4 2020. The $2-plus billion wasn’t inflated by the Beeple auction, according to nonfungible.com. Also excluded were sales of NBA Top Shots, video highlights converted into NFTs. NBA Top Shot trade on the Flow platform reached $472 million during Q1 2021.

BAND Royalty (operated by Singapore-based LIBERTY IS PTE LTD) is the leading innovator of music-focused NFTs. BAND is an entertainment technology-driven firm focused on the distribution of non-fungible tokens (NFTs) that allow fans to earn royalties from top songs and artists worldwide.

BAND Royalty lets fans take their enjoyment of music to the next level by offering blockchain-secured BAND NFTs that enable holders to earn crypto from some of the world’s most popular songs. This unique opportunity allows individuals to share in income streams each time a song in the BAND Royalty music catalog is performed.

BAND’s royalty pools leverage a performance music catalog featuring tracks from some of the biggest names in music, including Beyonce, Jay-Z, Justin Timberlake, Cher, will.i.am, Timbaland, Missy Elliott and Rihanna.

BAND Royalty NFTs

BAND NFTs, hosted on the ethereum blockchain, are a special type of NFT that can be staked into any one of three BAND Royalty Music Pools to receive a portion of all royalty streaming income from each track, for each royalty pool category. The BAND ecosystem is supported by multiple types of transactions:

  • Trading BAND Royalty NFTs – The first ever issuance of BAND NFTs is being offered to the public. Owners of the BAND NFTs will be able to trade them on the largest NFT marketplace, OpenSea, where the BAND NFTs are being launched on May 5, 2021.
  • Music Royalty Pools – These blockchain BAND NFTs have a special DeFi (decentralized finance) utility. Holders of BAND NFTs have the option to stake their tokens for a period of 90 days to five years, with longer stakes receiving proportionally increased amounts of the royalties share. Holders have the option to trade their BAND NFTs or stake them in one of three special music catalog pools that provide access to BAND music royalties. The three types of music pools available for staking are print music, mechanical/public performance and synchronization.

Through staking BAND NFTs, the holder can earn crypto from both BAND NFT trades on the OpenSea NFT marketplace and from the BAND music catalog royalty revenue.

The company intends to sell three more series of BAND NFTs, with 3,000 NFTs in each series. This strategy would cap the supply of BAND NFTs at a maximum of 12,000 units. As these NFTs are staked to capitalize on royalty opportunities, the supply of BAND NFTs available for trade is expected to be reduced, which the company then expects would increase the value of the BAND NFTs moving forward.

Market Opportunity

The market for NFTs has exploded in 2021, driven by rising media coverage and mainstream awareness. A well-known example is the first tweet by Twitter CEO Jack Dorsey, which was sold as an NFT for the equivalent of $2.9 million in March. This growth has been particularly apparent for art-focused NFTs, spearheaded by digital artist Beeple, who sold an NFT series titled “Everyday: The First 5000 Days” for over $69 million at auction during that same month.

The performance of the NFT space hasn’t just been confined to those big-ticket items. OpenSea, the largest NFT marketplace, reported monthly sales of over $95 million in February 2021 alone, up from $8 million the previous month. In total, over $400 million in NFT trading had taken place on the ethereum blockchain as of early April, with nearly half taking place from February to March 2021.

As Reuters reports, enthusiasts view NFTs as the future of ownership, and they solve the problem of monetization for digital artwork. Importantly, the report notes that “NFTs could also transform music.” The industry seems to agree.

In March 2020, Kings of Leon released their latest album, When You See Yourself, in the form of an NFT – a milestone in the history of the entertainment industry.

BAND Royalty is uniquely positioned to capitalize on the shifting landscape surrounding digital ownership as it continues to roll out its series of BAND NFTs in the months to come.

BAND Royalty Founders

The name BAND is the combination of the founders’ initials, Barnaby Andersun and Noble Drakoln.

Barnaby Andersun (BA) has spent years developing blockchain and cryptocurrency solutions, acting as CEO of BlockAlchemy, a blockchain, ecommerce and digital design consulting firm. Being involved in all aspects of web technologies since their conception in the early nineties has made Mr. Andersun a true pioneer in web development, ecommerce, branding, online marketing and blockchain. A sought-after international speaker, Mr. Andersun has been invited to speak on cryptocurrencies at Harvard and World Economic Forum, Davos, where he coordinated a blockchain digital asset conference, as well as Stanford University.

Noble Drakoln (ND) has been an avid music royalty investor for decades. He is also CEO of WarePlay Games Inc., a mobile AR/XR game design and development studio. Having started out as a futures and commodities broker at the age of 19 trading the E-mini S&P, gold futures contracts and treasury bond strips, he went on to author the Wiley & Sons-published best-selling books ‘Winning the Trading Game’ and ‘Trade Like a Pro’. Along with being a tech investor, financial author and sought-after speaker, Mr. Drakoln has been a contributing writer to Forbes and Futures Magazine, and a radio and T.V. financial commentator on Bloomberg and Fox Business News.

BAND Royalty is operated by Singapore based LIBERTY IS PTE. LTD, located at 23 New Industrial Road #04-09 Solstice Business Center Singapore 536209.


Recent News

chart

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC)

The QualityStocks Daily Newsletter would like to spotlight BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale.

BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands.

Based in British Columbia, Canada, BevCanna was founded in 2017.

End-to-End Turnkey Beverage Manufacturing Solutions

BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

  • Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
  • Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
  • Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
  • Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
  • Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands

BevCanna’s in-house brands include Pure Therapy and TRACE.

Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (CBD) products, throughout North America and Western Europe.

Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise.

TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels.

Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness.

TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots.

In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages.

Market Outlook for Cannabis-Infused Beverages

In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (https://ibn.fm/VkJfH).

The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces.

Management Team

Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand.

John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd.

Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years.

Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise.

Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL).

Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years.

Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries.

Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY).

BevCanna Enterprises Inc. (OTCQB: BVNNF), closed Friday’s trading session at $0.5615, off by 0.142273%, on 43,470 volume. The average volume for the last 3 months is 212,117 and the stock's 52-week low/high is $0.368/$1.20.

Recent News

Cybin Inc. (NEO: CYBN) (OTC: CLXPF)

The QualityStocks Daily Newsletter would like to spotlight Cybin Inc. (NEO: CYBN) (OTC: CLXPF).

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, announced that its Chief Executive Officer Doug Drysdale will be presenting at the Jefferies Virtual Health Care Conference 2021. Drysdale’s presentation is scheduled to begin at 1:00 p.m. Eastern Time on Tuesday, June 1, 2021. Interested parties should visit https://ibn.fm/Dx6YF to register for the webcast. The presentation will be webcast live via the above link, and a replay will be available for 30 days following the event. To view the full press release, visit https://ibn.fm/SlxYE

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.

Cybin Inc. (NEO: CYBN) (OTC: CLXPF), closed Friday’s trading session at $1.42, even for the day, on 142,476 volume. The average volume for the last 3 months is 438,059 and the stock's 52-week low/high is $0.078/$2.235.

Recent News

ev Transportation Services Inc.

The QualityStocks Daily Newsletter would like to spotlight ev Transportation Services Inc.

ev Transportation Services Inc. (“evTS”) develops and manufactures purpose built, all-electric light duty commercial vehicles and fleet management solutions.Founded in 2015 and based in Boston, the company is focused on producing vehicles that meet the needs of the essential services transportation and urban mobility markets. End-user applications for evTS vehicles include services such as security, parking enforcement, last mile urban delivery, building and grounds maintenance, meter reading, sanitation, university and corporate campuses, and warehouse operations.

ev Transportation Services Inc. (“evTS”) is a designer, developer and manufacturer of all-electric lightweight commercial vehicles and fleet management solutions.

Founded in 2015 in Brookline, Massachusetts, and currently based in Boston, the company is focused on the essential transportation services market. End-user applications for evTS vehicles include services such as security, parking enforcement, local small package delivery, meter reading, sanitation, parks and recreation, university and corporate campuses, and warehouse operations.

The FireFly ESV(R)

The company’s flagship product is the FireFly ESV(R), a high-performance, low-maintenance electric vehicle with zero emissions. This utility vehicle was created specifically to meet the needs of essential services users. The FireFly ESV utilizes the safest Lithium Ion battery technology available (LiFePO4, Lithium Iron Phosphate) for superior acceleration, improved energy efficiency and enhanced reliability. As a result, it boasts a range of 100+ miles on a single charge, further than any other electric vehicle in its class.

Additionally, its design can be modified according to the requirements of virtually any task and application, from parking enforcement and security to property and grounds maintenance, last mile urban delivery, on-campus tasks and more.

Parking Enforcement

The ideal parking specific vehicle (PSV), FireFly can be equipped with features that enable parking enforcement officers to do their jobs more effectively, significantly reducing operating costs while fully integrating with existing parking enforcement systems, including advanced license plate recognition programs. Key design features of the FireFly ESV that are critical for the successful execution of parking control tasks include:

  • High maneuverability with a tight turning radius and slim design, allowing the vehicle to maneuver on narrow streets and park in compact urban environments;
  • Electronically governed speeds of up to 50 mph in just seconds, allowing operators to quickly enter and keep up with fast moving traffic;
  • Full-height DuraGlide(TM) doors and low steps allowing for rapid ingress and egress on both sides of the vehicle;
  • Superior impact protection featuring an integrated safety cage and seatbelts;
  • A modular bed design allowing users to include a lockable or sectional bed to make room for boots, parking cones and other equipment; and
  • Friendly size and appearance, helping change the public’s perception of parking enforcement efforts.

Security

Specifically designed for flexible and quiet operation at low speeds, the FireFly ESV is an ideal vehicle for security and perimeter patrol tasks in different environments, including cities, office buildings, retail malls, prisons and educational institutions. With a range of 100+ miles, it allows security officers to patrol for the duration of an entire shift before returning to dispatch to recharge, thus generating savings compared to fuel-powered patrol vehicles. Key features that give the FireFly ESV a significant edge over its competition in security applications include:

  • Agility and speed, allowing officers to provide rapid response and engage in light pursuit at speeds exceeding 50 mph;
  • Comfort and security for the driver with the help of its tubular 2” steel roll cage and three-point safety harness;
  • High maneuverability with a 20-plus-degree approach angle and 6” of curb clearance, along with a tight turning radius; and
  • Low energy, high intensity lighting features for traffic control while idle for several hours.

Property and Grounds Maintenance

As a durable, customizable vehicle with minimal environmental impact, the FireFly ESV can be used for a wide range of maintenance operations on sidewalks and in recreation areas on a daily basis. Key features include:

  • A customizable modular design allowing the vehicle to be built according to use specific maintenance requirements, with features such as a sectional bed, an electronic lift dump, a refuse hauler, a van box, a utility bed with locking compartments and ladder racks, and other cleaning, sweeping or watering accessories;
  • A strong tubular steel frame and robust suspension design including the company’s proprietary DuraSteer(TM) front end featuring best-in-class anti-dive control and 1,100 pounds of payload capacity; and
  • A light, three-wheel design offering a tight turning radius and a small footprint, allowing FireFly to maneuver in landscaped areas, navigate around pylons and bollards, and operate in narrow corridors, indoors or out.

Last Mile Urban Delivery

Designed for short-range trips with stop-and-go driving, the 100% Electric FireFly ESV is ideal for delivery services in crowded urban environments, being able to accommodate anything from small packages and food delivery to spare parts, medical deliveries and more. Key features that make the vehicle a top choice for delivery services include:

  • More cargo space and hauling power than its competitors, due to its modular bed design and 1,100-pound payload capacity;
  • Speed and efficiency, as a fully licensable and street legal vehicle that can reach governed speeds of up to 50 mph;
  • Durability and maneuverability, making it a valuable addition to any delivery service’s vehicle fleet; and
  • Exceptionally low cost of operation, as a virtually maintenance-free vehicle with long-lasting battery power.

The Firefly ESV 2021 Model

On September 15, 2020, the company announced the new 2021 model of its Firefly ESV vehicle. This model will retain all of its predecessor’s original components, with added features for the new 2021 line. The upgrades and new features include, but are not limited to:

  • Larger door for easier vehicle access;
  • More legroom within the cab;
  • Improved visibility through the redesigned windshield;
  • New rear bed accessory attachment options to better accommodate specific service industries; and
  • An optional trailer hitch with electronic braking control.

Each vehicle will also be equipped with the evTS Connected Vehicle System, which includes in-vehicle Wi-Fi, an internet-accessible vehicle management system, the ability to perform remote diagnostics, low battery alerts and optional 360-degree video monitoring that runs in real-time.

In a news release, David Solomont, CEO of evTS, stated, “The 2021 FireFly is our best and most advanced model yet and will enable evTS to fill the critical and rapidly expanding need for essential service vehicles, particularly for last-mile on-demand urban delivery vehicles.”

Deal with ADOMANI

In April 2020, ADOMANI Inc. (OTCQB: ADOM) signed a letter of intent to purchase 120 FireFly ESV vehicles from evTS. Under the agreement, ADOMANI, a leading provider of zero-emission purpose-built electric vehicles and drivetrain solutions, serves as a distributor of current and future evTS electric vehicle offerings in the state of California.

In addition, ADOMANI may perform final assembly and testing activities of evTS vehicles, as well as warranty repair services, at its recently-opened assembly factory in Corona, California – a location that’s close to urban centers and a variety of terrains where the FireFly ESV can be utilized, according to ADOMANI COO Rick Eckert.

“The agreement with ADOMANI represents a major milestone for evTS, and we are excited to explore a partnership with them,” Solomont added. “Our FireFly ESV all-electric lightweight commercial utility vehicle is a perfect complement to their existing lineup of EVs, and we expect to significantly expand our sales in California and surrounding states based on the quality and reach of ADOMANI’s sales, service and support organization.”

Electric Vehicle Market

In 2019, the global electric vehicle market was valued at $162.34 billion. Registering a CAGR of 22.6%, the market is projected to reach $802.81 billion by 2027, according to an Allied Market Research report (https://nnw.fm/JAMbl).

Essential services fleet vehicles represent a replacement market of approximately 100,000 vehicles. These vehicles roughly translate to a $2.5-billion market opportunity each year.

Management Team

David Solomont is the Founder and CEO of evTS. He has over 40 years of experience in information technology, software and interactive media. He is an active investor and advisor to early-stage tech companies. Solomont has a bachelor’s degree in engineering from Tufts University and a master’s degree in management from MIT’s Sloan School.

Greg Horne is the Chief Technology Officer at evTS. He directs the company’s vehicle development efforts and is responsible for the new model year of the FireFly ESV being brought to market. He previously served as CTO of eFleets Corporation, worked on software and flight testing for the Bell/Boeing V-22 Osprey and served as a design engineer at Bell Helicopter.

Jim Sabitus is the company’s Vice President of Operations. He has experience as a corporate executive leading emerging and established publicly traded companies. Sabitus’ previous roles include CEO of Row One Brands Inc., CFO of Modern Shoe Company and various management roles at Converse Inc.

Paul Barrett is evTS’ Vice President of Marketing and Product. He is an experienced senior executive and serial entrepreneur with 45 years of experience in the automotive and electronics industries. His prior roles include serving as COO of Fixed Ops Pros, NavResearch and Cimble Corporation. Barrett also held numerous executive positions during his 20+ years at LoJack Corporation.

Eric Burmeister is the company’s Vice President of Sales and Business Development. He has held a number of positions within the specialized vehicle industry. Prior to joining evTS, he was the Director of National Sales and Business Development for Westward Industries. Burmeister also held national and regional sales positions for eFleets, Global Electric Motors and ZENN Motor Company.

Michael Tepfer is the company’s Vice President of Manufacturing Engineering. He is also the current president of Integrity Global Manufacturing Ltd. He has 30 years of experience in project management and oversight of overseas manufacturing businesses.

Todd Marcucci is evTS’ Director of Customer Satisfaction. He is a former Vice President of Research and Development for eFleets. He assembled and led a team that designed, supported and produced the original FireFly ESV. Marcucci has worked as a consultant for numerous projects related to electric vehicle powertrains.


Recent News

chart

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF)

The QualityStocks Daily Newsletter would like to spotlight GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF).

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) was featured in a publication from MiningNewsWire, examining how the Pacific Northwest National Laboratory, under the U.S. Department of Energy and in collaboration with Moselle Technologies, recently launched a technology that utilizes magnetic nanoparticles to extract valuable minerals from brine.

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (formerly Altum Resources Corp.), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently announced its entry into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile that hosts over 100 million ounces of gold within the last 10 years.

Chilean Gold Properties Being Acquired

On April 17, 2020, GoldHaven Resources entered into an agreement to purchase a 100% interest in two gold projects located in the Maricunga Gold Belt of Northern Chile. The first property, Rio Loa, is located 25 kilometers south of Gold Fields Ltd.’s Salares Norte, where, this year, a five-million-ounce discovery was made. The second property, Coya, is located only 10 kilometers east of the Kinross La Coipa open pit mine, which has produced over 7.5 million ounces of gold to date.

Rio Loa Project

Initial geophysical studies of the Rio Loa site have exposed highly anomalous ardennite and lead values, a key characteristic of gold mineralization within silicified resistive bodies. The studies have also produced initial findings which are similar to those seen at contiguous mines, such as Salares Norte (operated by Gold Fields), which has over five million ounces in estimated gold deposits.

The potential economics for the site look particularly promising when taking the unit costs at the neighboring Salares Norte mine into account. Gold Fields has estimated that its production AISC (all-in sustainable costs) will approximate $552 per ounce and have forecast a 2.3-year payback period for its initial investment, assuming a $1,300 per ounce gold price.

Coya Project

The Coya site is located within close proximity to one of the richest and largest epithermal gold and silver districts in Chile and is in close proximity to active mining sites, specifically the La Coipa mine owned by Kinross. A study carried out in 2017-2018 on the Coya site of 796 rock chip samples found favorable gold and silver values, in some cases ranking as high as 764 grams/tonne of gold and 719 grams/tonne of silver – values which are near certain indicators of potential gold and silver deposits. The La Coipa mine (Kinross) has produced over 6.9 million ounces of gold to date.

On August 11, 2020, GoldHaven Resources acquired five potential gold projects in the Maricunga Gold Belt of Northern Chile. The Maricunga hosts discoveries within the last 10 years of over 100 million ounces of gold and over 450 million ounces of silver. These newly acquired properties are in close proximity to seven other mines, which possess an estimated aggregate of 81 million ounces of gold in total reserves.

GoldHaven’s five new projects cover a total area of approximately 22,600 hectares, or 226 square kilometers, located in the northern portion of the Maricunga Belt in proximity to the 5 million-ounce gold equivalent Salares Norte project owned by Gold Fields. Gold Fields announced in April 2020 its intention to proceed with the development of Salares Norte at a cost of $860 million, with a $138 million expenditure budgeted for 2020.

The Maricunga Belt extends approximately 150 kilometers north-south and 30 kilometers east-west, straddling the border between Chile and Argentina. This region hosts known mineral resources of more than 100 million ounces of gold, 450 million ounces of silver and 1.3 billion pounds of copper.

The Maricunga project’s opportunity came about as a result of a $150 million initiative launched by the Chilean Economic Development Agency (“CORFO”), with the objective of encouraging exploration and mining prosperity in Chile and strengthening Chile’s position as a world leader in the sector.

As part of CORFO’s program, a total of $15.3 million was given to private equity fund IMT Exploration to evaluate 403 projects, beginning in 2011. This led to a generative program carried out from 2016 to 2019, resulting in 126 potential epithermal targets from which 57 field evaluations were made. Due diligence work followed on 19 of these. Work programs were then conducted, including geological mapping, rock and soil sampling and TerraSpec (PIMA) analyses on geochemical grids for alteration mapping, and, as a result, the five high-priority Maricunga projects were identified. No drilling has been carried out on any of the Maricunga projects.

Securing Financing for Upcoming Operations

In conjunction with its announcement regarding its acquisition of five Chilean mining interests, GoldHaven Resources also detailed plans for a non-brokered private placement of 11.5 million units at a price of $0.35 per unit, for gross proceeds of $4,025,000. Each unit will consist of one share of the company and one warrant, the latter of which can be exercised to acquire an additional share of the company for a period of 18 months from the date of issuance at a price of $0.50 per share. Net proceeds from the offering are intended to be used to fund general expenses, as well as exploration and drilling of its mineral properties.

Gold Prices Hit Record High in 2020

Gold prices have been on a remarkable run in 2020, breaking above $2,000 per ounce for the first time on record. Having begun the year at $1,515 per ounce, the precious metal has seen a huge surge on the back of widespread economic uncertainty stemming from governments’ worldwide propensity to expand the money supply, from the reduction of the value of the U.S. dollar as expressed by the decrease in the U.S. dollar index, and from the very real economic effects of the COVID-19 pandemic.

Global central banks have carried out 144 interest rate cuts thus far in 2020, reducing rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures has prompted a number of investment banks to boost their near-term outlooks for gold prices, with Bank of America raising its 18-month gold price target to $3,000 per ounce (http://nnw.fm/PQJtc).

Leadership Team

David Smith, President, CEO and Director, has been immersed in the mining industry for the last eight years, working in corporate development and finance. Prior to GoldHaven Resources, Smith cofounded a multifaceted real estate development and sales company, which has now been in operation for over 35 years. He also cofounded two successful environment-focused companies listed on the Toronto Stock Exchange. Both companies were sold independently and returned a significant profit for shareholders.

Darryl Jones, Chief Financial Officer, is a finance executive and CPA with over 30 years of public company and project buildout experience. Most recently, Jones served as the CFO of Lupaka Gold Corp., retiring in June 2018. Prior to that, Jones serves as CFO of Corriente Resources, which was sold to CRCC-Tongguan in May 2010 for C$680 million.

Patrick Burns, VP Exploration and Director, is a Canadian geologist with over 40 years of experience throughout the Caribbean and Central and South America. He played a direct role in the discovery of the Escondida porphyry copper deposit in Chile and has been involved in publicly traded mining companies, predominantly in Chile, for 35 years.

Marla Ritchie, Corporate Secretary, brings over 25 years of experience in public markets to the GoldHaven team. Throughout this time, she has worked as an administrator and corporate secretary specializing in resource-based exploration companies. Currently, Ritchie is the corporate secretary for several companies, including International Tower Hill Mines Ltd. and Trevali Mining Corp.

Gordon Ellis, Director; has over 50 years’ experience in mining and resource development. A professional engineer and entrepreneur, he has held multiple senior management and director roles with public mining companies, as well as a multi-billion-dollar ETF fund. Ellis holds an MBA in international finance and a Chartered Directors designation.

Scott Dunbar, Director is a professor and head of multiple departments at the University of British Columbia, including mineral extraction and mining innovation, as well as mining engineering. He has been involved in projects around the world in regard to mining exploration, geotechnical engineering and mine design. Dunbar received his PhD in geophysics and civil engineering from Stanford University.

GoldHaven Resources Corp. (OTCQB: GHVNF), closed Friday’s trading session at $0.4392, up 7.8585%, on 95,250 volume. The average volume for the last 3 months is 100,340 and the stock's 52-week low/high is $0.257/$0.87.

Recent News

Kaival Brands Innovations Group Inc. (KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

Kaival Brands (OTC: KAVL), a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets, has announced that all 11 varieties of Bidi Vapor's Bidi(R) Stick devices are included on the U.S. Food and Drug Administration's ("FDA") recently released list of what it has deemed new tobacco products. KAVL is the exclusive global distributor of all Bidi Vapor LLC products. The announcement noted that the FDA release is a list of ENDS products that met certain requirements, including submitting a Premarket Tobacco Product Application ("PMTA”) to the FDA by Sept. 9, 2020, which was the deadline for currently marketed products. The announcement also observed that Bidi Vapor’s flagship product, the BIDI stick, has been named the fastest-growing, closed-system, disposable electronic nicotine delivery system (“ENDS”) product in the country, according to a recent Nielsen market share data report for the 52-week period ending March 27, 2021. In addition, the Bidi Stick is the only ENDS on the market that participates in a mass-recycling program. Dubbed BIDI Cares, the program is now undergoing a comprehensive PMTA review with the FDA. To view the full press release, visit https://ibn.fm/5JXHx

Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (KAVL), closed Friday’s trading session at $1.25, even for the day, on 40,898 volume. The average volume for the last 3 months is 199,410 and the stock's 52-week low/high is $0.0502/$2.02629995.

Recent News

Knightscope, Inc.

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc..

Knightscope, Inc., founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities and are on target to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics and artificial intelligence.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including ten Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country, despite the pandemic (note: robots are immune).

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire.

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology;
  • Operating for more than one million hours in the field and securing contracts across five time zones;
  • Navigating through the global pandemic without interruption by continuing to operate on a daily basis across the nation and supporting clients classified as essential services; and
  • Continuing its hiring processes despite the current societal and economic disruption.

Growth Capital

With more than 10,000 investors and over $40 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

The company is presently in the process of raising up to $50 million in growth capital as it prepares for a potential public listing. Knightscope has reserved ticker symbol ‘KSCP’ with Nasdaq.

Investors can buy shares exclusively through the company’s managing broker-dealer, StartEngine (http://nnw.fm/l9GLX) until July 20, 2020. Concurrent with this live offering and contingent upon various factors, including raising a sufficient amount of funds and meeting applicable listing standards, the company intends to begin preparation of an S-1 format Form 1-A and Nasdaq Capital Market application in anticipation of a possible public listing of the stock at the conclusion of the Regulation A+ offering.

Company Mission — The Greater Good

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting millions of law enforcement and security professionals across the country.

Crime has a negative economic impact in excess of $1 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was recently interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one to one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings — and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $4 to $11 per hour, compared with approximately $85 and $30 per hour for an armed off duty law enforcement officer and an unarmed security guard, respectively.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has four patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’.

The ASRs and all the related technologies were developed ground up by the Company and are Made in the USA.

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.


Recent News

chart

Lottery.com

The QualityStocks Daily Newsletter would like to spotlight Lottery.com.

Lottery.com is a next generation platform where consumers can play the lottery online – in browser or via smartphone app. The platform offers users access to official lottery games sanctioned by their individual states and also provides lottery data to more than 400 digital publishers, including Google and Amazon Alexa.

Lottery.com was founded in 2015, launching at the LAUNCH festival and soon turning into a leader in the industry. With headquarters in Austin, Texas, the company is dedicated to helping advance the lottery industry into the digital age and works closely with state regulatory bodies to achieve this goal.

The company recently entered into a definitive agreement for a business combination with special purpose acquisition company Trident Acquisitions Corp. (NASDAQ: TDAC) (“Trident”), which will result in Lottery.com becoming a publicly listed company. Once the transaction is complete, the combined company will be trademarked as Lottery.com, with its common stock to remain listed on Nasdaq under ticker symbol ‘LTRY’.

Lottery.com Online Platform

The Lottery.com online platform works closely with state regulators, advancing the lottery into the digital age. With the online platform, the company offers enhanced regulatory capabilities by leveraging innovative blockchain technology and capturing the untapped market of digitally native players.

Players go online in a browser or through a mobile application to use the interface. The process includes:

  • Players Choose a Game: Players can play officially state sanctioned multi-state games and other games offered in the states in which they live. Players can also find winning numbers, jackpot totals, draw dates and more for hundreds of other lottery games around the world.
  • Players Pick Numbers: Players can play their lucky numbers or do a quick pick of randomized numbers in as simple as two taps. “Tap, Tap, Ticket!”
  • A Safe and Secure Way to Play: Purchases for up to 50 tickets can be made at one time through the online interface. Lottery.com handles everything after purchase, letting users know when they win.
  • Collect All Winnings: Consumers keep 100% of their winnings. All winnings stay in the Lottery.com balance for future ticket purchases, or a cashout can be requested. Company representatives contact winners who hit big jackpots, instructing them on the redemption process.

A Better Way to Play the Lottery

Lottery.com has an innovative e-commerce platform that is using blockchain to maintain an accurate ledger. From 2016 to 2020, Lottery.com grew gross revenue at a CAGR of 363%, and it forecasts gross revenue equal to approximately $71 million in 2021, $279 million in 2022, and $571 million in 2023.

Lottery.com is leveraging a successful playbook, with $398 billion in global lottery sales but only 6.7% online penetration. The large market opportunity is expected to shift to online transactions within the next decade.

The platform is currently available in 12 states across the United States, and the company plans to expand to 34 by the end of 2023. Global expansion is also on the horizon, with partnership plans in Turkey and Ukraine.

Key features that make the Lottery.com experience unique include:

  • All the Games Users Love – For consumers who live in applicable LIVE states, Powerball and Mega Millions are available right from the mobile application.
  • Convenience – Lottery.com makes playing the lottery on mobile devices easy. After setting up an account, users can begin playing in moments or set reminders to play when the jackpot is high.
  • Easy Cashouts – Users can cash out winnings straight to a bank account, safely and securely, with no commissions.

The company is also gamifying charitable giving, fundamentally changing how nonprofits engage with donors and raise funds. WinTogether.org is a platform designed to offer charitable donation sweepstakes to incentivize donors to take action by offering large cash prizes and once-in-a-lifetime experiences.

Strong Advisory Board Presence

Lottery.com is expected to continue to gain support, leaning on the experience of its advisory board and notable investors from the venture capital, gaming and entertainment industries. These include:

  • Jason Robins, CEO of DraftKings Inc. (NASDAQ: DKNG)
  • Ben Narasin, Venture Partner of NEA
  • Peter Diamandis, Chairman of XPRIZE Foundation
  • Matthew Le Merle, Co-Founder and Managing Partner of Fifth Era and Keiretsu Capital
  • Paraag Marathe, President of Enterprises and EVP of Football Operations for the San Francisco 49ers
  • Jamie Gold, The Poker Philanthropist

Management Team

Tony DiMatteo is the Co-Founder and Chief Executive Officer of Lottery.com. He is a serial entrepreneur and highly sought-after industry speaker and thought leader. He has been featured in The Wall Street Journal, Forbes, VentureBeat, TechCrunch Inc. and more for his approach to entrepreneurship, the gaming industry and cryptocurrency.

Matt Clemenson is the Co-Founder and Chief Commercial Officer of Lottery.com. He is responsible for the company’s strategy. Mr. Clemenson was steeped in corporate and enterprise engineering processes at Hotwire and Expedia before going on to be CEO at LesConcierges, the world’s largest concierge company, which merged into John Paul and sold to Accor Hotels. Clemenson and DiMatteo have been partners for more than 10 years.

Ryan Dickinson is the company’s President and Chief Operating Officer. He has a diverse background in business, technology, product, design and sales, which has aided him in producing many successful outcomes throughout his career. Notably, as Senior Vice President of a SaaS company, Mr. Dickinson produced profitability from a negative $1.4 million division within the first year by reinventing the product offerings, streamlining processes and establishing a go-to-market strategy. Additionally, he produced three record breaking revenue years in a row for AccuWeather, the world’s largest weather provider, by increasing every KPI for all flagship properties by no less than 5%.

Luc Vanhal is the company’s Chief Financial Officer. He has served in C-level executive roles since the 1990s, including a nine-year tenure for The Walt Disney Company (NYSE: DIS) from 1990 to 1999. From 2001 to 2004, he managed the development of the World of Warcraft massively multiplayer game, which, by the end of 2020, still had over five million active subscribers. As the CFO of Lottery.com, Mr. Vanhal leads the company’s global finance organization, with treasury responsibility, accounting, analysis and financial planning.


Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis branded products company in the U.S., released its unaudited financial and operational results for the three months ended March 31, 2021, expressed in U.S. dollars. These filings are available for review on the Company’s SEDAR profile at www.sedar.com and on the Canadian Securities Exchange (the “CSE”) website at www.thecse.com. The Company also announced today that Nathan Pearson, Chief Financial Officer, will be leaving the Company at the end of this month. The Company is pleased to announce that Tessa O’Dowd, who has served as the Company’s Controller for the last three years, has been appointed as the Company’s Chief Financial Officer.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday’s trading session at $0.4369, off by 1.588%, on 10,492 volume. The average volume for the last 3 months is 91,085 and the stock's 52-week low/high is $0.349999994/$1.85000002.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, reported its financial results for first quarter 2021, the period ending March 31, 2021 (https://ibn.fm/kUVwH). The company also released key business updates along with its financial numbers.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Friday’s trading session at $1.18, up 3.5088%, on 803,756 volume. The average volume for the last 3 months is 2,647,579 and the stock's 52-week low/high is $0.0152/$1.47000002.

Recent News

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF)

The QualityStocks Daily Newsletter would like to spotlight TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF).

TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) recently commissioned a two-part market research study, conducted by Toronto-based market research firm Burak Jacobson Partners Inc., to gain practical and theoretical insights to guide its near-term business decisions. The commissioning followed the company’s launch of its flagship product — TAAT(TM) — a tobacco-free and nicotine-free alternative to cigarettes in Q4 2020. “The study specifically focused on response to the TAAT concept, brand image and product user experience,” a recent article reads. According to TAAT CEO Setti Coscarella, feedback from the respondents reinforced the company’s belief that it has several competitive advantages, including selling its product online, its nicotine-free and tobacco-free attributes, and an attractive price point compared to tobacco cigarettes. “As we expand our market footprint in 2021, we intend to capitalize on these advantages to capture the interest of smokers aged 21+ and further establish TAAT as a better choice and a recognized brand name in the tobacco category.” To view the full article, visit https://ibn.fm/NctOv

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) is a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco.

The key players of TAAT Lifestyle & Wellness are from leading tobacco brands. They are guiding the mission with the company’s proprietary product, TAAT(TM), which uses the company’s proprietary Beyond Tobacco(TM) base material. The base material undergoes a 14-step process to taste and smell just like tobacco and uses a patent-pending refinement technique.

This provides the company with unique opportunities on the global tobacco market, which was estimated at $849 billion in 2019, with approximately 1.3 billion people using tobacco in some form worldwide (https://nnw.fm/bvKFL).

TAAT Lifestyle & Wellness was founded in 2006 and is headquartered in Vancouver, Canada, with operations in Las Vegas, Nevada.

TAAT(TM)

TAAT is a smokable alternative to tobacco cigarettes using the Beyond Tobacco base material, which contains zero tobacco and zero nicotine. The current TAAT offering comes in three varieties: Original, Smooth and Menthol, which were launched during Q4 2020 in Ohio. The company’s Ohio tobacco wholesaler also distributes for major tobacco industry names such as Altria, RJ Reynolds (a subsidiary of British American Tobacco) and ITG.

The TAAT Beyond Tobacco experience was created to replicate the sensory elements of smoking a tobacco cigarette. Market testing in California and Nevada reached a consensus that TAAT products offered no significant differences in experience when compared to tobacco cigarettes, in terms of the following aspects:

  • Visual – the nearly identical product packaging and enhanced smoke volume
  • Auditory – the “crackling” sound of the base material when it is ignited
  • Smell – when burning, TAAT emits a tobacco-like scent
  • Taste – the patent-pending Beyond Tobacco base material undergoes a refinement process that creates a tobacco-like taste
  • Touch – TAAT satisfies the “hand-to-mouth” fixation and motor habits, such as flicking ashes

TAAT Beyond Tobacco Targeting Current Smokers

TAAT Lifestyle & Wellness is currently targeting the market of legal-aged smokers with its proprietary product. The company aims “not to create a new problem, but to solve an existing one.” TAAT Lifestyle & Wellness offers a non-addictive alternative to tobacco, with several competitive advantages making it a promising option on the United States market, such as:

  • Price – TAAT can be offered at a lower price than competing products in the tobacco category, which adds to the propositioned value for current legal-aged smokers.
  • Experience – TAAT appeals to current smokers who wish to give up the tobacco and nicotine but keep the smoking experience they enjoy.
  • Branding/Packaging – TAAT is American-grown and American-made, with its Beyond Tobacco base material serving as a legacy to the combustible tobacco products.

The current alternatives to cigarette smoking do not offer a comparable experience. Previously marketed products, like vaping, proved difficult for some legal-aged smokers to adopt, as the experience was too different from traditional cigarettes.

Market Outlook

In 2016, the United States tobacco market was valued at over $100 billion, a number that’s expected to grow over the next decade (https://nnw.fm/yd8oP). In terms of volume, over 215 billion cigarettes were sold to roughly 34 million adults in the United States in 2018. These numbers represent almost 14% of the adult population. Of those, almost two-thirds smoked more than 15 cigarettes in one day. A standard pack is comprised of 20 cigarettes.

The company’s Beyond Tobacco, as a non-tobacco product, has a price-driven consumer advantage in many states. While state taxes on traditional cigarettes vary, most tend to average around $1.82 per pack. Washington D.C. is on the higher end of the tax spectrum at $4.50 per pack, whereas Missouri is only $0.17 per pack (https://nnw.fm/D3WnT).

TAAT Lifestyle & Wellness estimates that, if one pack of TAAT Beyond Tobacco was sold at 20% of all United States tobacco points of sale, the product would capture 0.25% of the market, the equivalent of approximately 2.7 million cartons of cigarettes per year.

Management Team

Setti Coscarella is the Chief Executive Officer of TAAT Lifestyle & Wellness Ltd. He is experienced in investment banking, private equity and entrepreneurship. In 2017, Mr. Coscarella was the lead strategist for Reduced-Risk Products at Philip Morris International. While there, he worked with thousands of smokers to better understand how to position smoking alternatives, developing programs that could help smokers convert to reduced-risk products. Mr. Coscarella holds an MBA from the Schulich School of Business, specializing in finance, marketing and corporate strategy. He also has a Bachelor of Science in mathematics and physics from the University of Toronto.

Tim Corkum is the company’s Chief Revenue Officer. He has a lengthy history in the tobacco industry, having served 21 years at Philip Morris International. Mr. Corkum has experience leading the international commercialization of combustible cigarettes and working on reduced-risk product offerings. During his 21-year tenure, he held senior positions in business development, sales strategy, key account management and corporate affairs. He holds a BA from Carleton University with a concentration in law.

Joe Deighan is Founder of TAAT Lifestyle & Wellness and oversees research and development. He is the founder of vape liquid ‘JJuice’, created in 2012. JJuice was distributed across all of the United States and in 26 other countries, alongside the private label production that was done for other brands. Mr. Deighan sold JJuice in a cash deal that was valued at over $800,000 in 2017. He currently handles all R&D and production for Beyond Tobacco, knowing the product better than anyone else in the company.

TAAT Lifestyle & Wellness Ltd. (TOBAF), closed Friday’s trading session at $2.72, off by 1.1125%, on 84,950 volume. The average volume for the last 3 months is 222,695 and the stock's 52-week low/high is $0.086999997/$0.45719999.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Monday's trading